Meeting
2017 Gastrointestinal Cancers Symposium
Phase II study of intraperitoneal paclitaxel plus S-1/paclitaxel for gastric cancer with positive peritoneal cytology: CY-PHOENIX trial.
Authors
Masaki Aizawa
Niigata Cancer Center Hospital, Niigata, Japan
Masaki Aizawa , Hironori Ishigami , Hiroshi Yabusaki , Atsushi Nashimoto , Haruhiko Imamoto , Motohiro Imano , Hiroharu Yamashita , Kentaro Kishi , Yasuhiro Kodera , Yoshikazu Uenosono , Yoshiyuki Fujiwara , Akio Hidemura , Shigeyuki Tamura , Ryoji Fukushima , Hironori Yamaguchi , Joji Kitayama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
UMIN000002850
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 96)
DOI
10.1200/JCO.2017.35.4_suppl.96
Abstract #
96
Poster Bd #
H8
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Phase II study of intraperitoneal paclitaxel combined with S-1 plus cisplatin for gastric cancer with peritoneal metastasis: SP + IP PTX trial.
First Author: Daisuke Kobayashi
Poster
2018 ASCO Annual Meeting
A phase II study of perioperative intraperitoneal paclitaxel plus S-1/paclitaxel for curatively resectable gastric cancer with serosal invasion: The GAPS study.
First Author: Seiji Ito
Poster
2017 ASCO Annual Meeting
Phase II study of intraperitoneal docetaxel plus capecitabine/cisplatin for gastric cancer with peritoneal metastasis: XP+IP DOC trial.
First Author: Ryoji Fukushima
Poster
2017 Gastrointestinal Cancers Symposium
Exploratory study of intraperitoneal paclitaxel plus mFOLFOX6 for gastric cancer patients with peritoneal metastasis and inadequate oral intake.
First Author: Shuntaro Yoshida